Ayurveda Medicines for Treating Lifestyle Diseases
Ministry of AYUSH in
collaboration with Ministry of Health & Family Welfare has implemented a
project viz Integration of AYUSH (Ayurveda) with National Programme for
Prevention and Control of Cancer, Diabetes, Cardio-vascular Diseases and Stroke
(NPCDCS) program in the identified Districts. So far 9,87,446 patients have
been screened and 93117 patients have been enrolled for long term management
through Ayurveda interventions, Lifestyle modifications and Yoga.
Central Council for Research in Ayurvedic Sciences (CCRAS), under Ministry of AYUSH has developed AYUSH-82, a formulation through extensive research methodologies and the same has been commercialised for further benefit of public at large.
CCRAS has developed AYUSH-QOL-2C for improving Quality of life of breast & cervical cancer patients in collaboration with All India Institute of Medical Sciences (AIIMS), Delhi and St. Jones Medical College (Bengaluru).
In addition to this, CCRAS has validated 82 classical Ayurvedic formulations and 11 new drugs on more than 32 diseases conditions, lifestyle diseases such as Diabetes, Bronchial Asthma, Hypertension, Irritable Bowel Syndrome (IBS), Iron deficiency anaemic, Osteoarthritis, Rheumatoid arthritis, Haemorrhoids, Computer vision Syndrome, Obesity etc.
To encourage the export of AYUSH products, under Central Sector Scheme for promotion of International Cooperation, (IC Scheme), incentives are provided to AYUSH drug manufacturers, entrepreneurs, AYUSH institutions and Hospitals etc. for registration of AYUSH products (Market Authorisation) with regulatory bodies of different countries such as Food and Drug Administration of United States (USFDA)/ Europe, the Middle East and Africa (EMEA)/ Medicines and Healthcare products Regulatory Agency of United Kingdom (UK-MHRA)/ Natural and Non-prescription Health Products Directorate of Canada (NHPD) etc.
This information was given by the Minister of State (Independent Charge) for AYUSH, Shri Shripad Yesso Naik in written reply to a question in Rajya Sabha .